Gabriela Gautier-Vargas

7PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersMolecular targetsTransplantation immunologyInfectious diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 17, 2022
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients.

Ilies Benotmane, Aurélie Velay, Gabriela Gautier-Vargas

|Feb 01, 2022
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.

Xavier Charmetant, Maxime Espi, Ilies Benotmane

|Dec 28, 2020
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients.

Ilies Benotmane, Gabriela Gautier Vargas, Aurélie Velay

|Oct 13, 2020
SARS-CoV-2 viral dynamics in immunocompromised patients.

Sophie Caillard, Ilies Benotmane, Gabriela Gautier Vargas

|Aug 11, 2020
In-depth virological assessment of kidney transplant recipients with COVID-19.

Ilies Benotmane, Gabriela Gautier-Vargas, Marie-Josée Wendling

|Aug 03, 2020
Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-Results from a proof-of-concept study.

Ilies Benotmane, Morgane Solis, Aurélie Velay

Pageof 2

Frequent Collaborators

7 joint publications

Ilies Benotmane

6 joint publications

Samira Fafi-Kremer

5 joint publications

Sophie Caillard

4 joint publications

Noëlle Cognard